Integra Lifesciences Holdings Corp (IART, Financial) experienced a notable stock price increase of 5.19%. The stock's price reached $19.04 per share with a trading volume of 553,162 shares and a turnover rate of 0.71%. The stock's volatility was marked at 6.30%.
Recent financial reports revealed revenue of $418 million, a net loss of $12.4 million, earnings per share of -$0.16, and a gross profit of $232 million. The company's price-to-earnings (P/E) ratio stands at 65.52. Among the 14 institutions providing ratings, 21% recommend buying, 50% suggest holding, and 29% advise selling.
Within the medical devices sector, where Integra operates, there was an average decline of 0.36%. Notable performers in the sector included Spectral Ai, Inc., Sintx Technologies, Inc., and Heartsciences Inc C/Wts (To Pur Com), all showing significant gains. Active stocks in the sector include Nuwellis, Inc., Tenon Medical, Inc., and Sintx Technologies, Inc., with turnover rates of 43.45%, 39.45%, and 8.05% respectively. Heartsciences Inc C/Wts (To Pur Com), Dih Holdings Us Inc C/Wts 20/04/2028 (To Pur Com), and Baird Medical Investment Holdings Ltd showed notable volatility.
Integra Lifesciences, based in New Jersey, specializes in medical devices for regenerative therapy, orthopedic, and neurosurgical applications. It operates through two main divisions: Codman Specialty Surgical and Tissue Technologies, with Codman being the largest revenue generator. Integra serves markets in Europe, the Asia-Pacific region, and other global areas, with significant income from domestic sales.
